1. Volume 130, Issue 6, Pages 1808-1816 (December 2006)
Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular- Weight Heparin Compared With Oral Anticoagulants? 
Ferretti Gianluigi , MD, PhD, Bria Emilio , MD, Giannarelli Diana , MD, PhD, Carlini Paolo , MD, Felici Alessandra , MD, Mandalà Mario , MD, Papaldo Paola , MD, Fabi Alessandra , MD, Ciccarese Mariangela , MD, Cuppone Federica , MD, Cecere Fabiana Letizia , MD, Nuzzo Carmen , MD, Terzoli Edmondo , MD, Cognetti Francesco , MD 
CHEST 
Volume 130, Issue 6, Pages (December 2006)
DOI: /chest
Copyright © 2006 The American College of Chest Physicians Terms and Conditions

2. Figure 1 Flow diagram. RCTs = randomized controlled trials.
CHEST  , DOI: ( /chest )
Copyright © 2006 The American College of Chest Physicians Terms and Conditions

3. Figure 2
VTE during follow-up after active anticoagulant treatment. Effect = RR; Lower = 95% CI RR lower limit; Upper = 95% CI RR upper limit; Ntotal = total number of patients; Fixed Combined = fixed-effect model estimation; Random Combined = random-effect model estimation. OA = oral anticoagulants. Treated = patients receiving LMWH; Control = patients receiving oral antagonists.
CHEST  , DOI: ( /chest )
Copyright © 2006 The American College of Chest Physicians Terms and Conditions

4. Figure 3
VTE during active anticoagulant treatment. See Figure 2 for explanation of terms.
CHEST  , DOI: ( /chest )
Copyright © 2006 The American College of Chest Physicians Terms and Conditions

5. Figure 4
VTE during active anticoagulant treatment in cancer patients. See Figure 2 for explanation of terms.
CHEST  , DOI: ( /chest )
Copyright © 2006 The American College of Chest Physicians Terms and Conditions

6. Figure 5
Funnel plot of SE by effect size concerning those studies8,1011,1213,14,15 selected for assessing recurrent VTE during follow-up after cessation of active treatment.
CHEST  , DOI: ( /chest )
Copyright © 2006 The American College of Chest Physicians Terms and Conditions